CDK4/6-targeted therapy for gastrointestinal cancers: from resistance mechanisms to immuno-combination strategies guided by biomarkers - Quiz - MDSpire

Targeting CDK4/6 in Gastrointestinal Malignancies: Exploring Resistance Mechanisms and Biomarker-Driven Immunotherapy Combinations

  • By

  • Junhao Cui

  • Yanchuan Zhang

  • Yongfang Wu

  • Guangjie Zhang

  • Jie Lan

  • Yingshuang Wang

  • June 4, 2026

Share

Original Source(s)

CDK4/6-targeted therapy for gastrointestinal cancers: from resistance mechanisms to immuno-combination strategies guided by biomarkers

  • by Junhao Cui, Yanchuan Zhang, Yongfang Wu, Guangjie Zhang, Jie Lan, Yingshuang Wang

  • June 4, 2026

Related Content

A double-edged sword: the role of macrophage pyroptosis-driven cytokine storm-mediated intercellular communication in tumor progression

Clinical characteristics of pediatric tumor-induced osteomalacia: a systematic review and individual patient data analysis

Treatment patterns and survival outcomes in elderly patients with intrahepatic cholangiocarcinoma: NCDB analysis